申请人:Pliant Therapeutics, Inc.
公开号:US20200109141A1
公开(公告)日:2020-04-09
The invention relates to compounds of formula (I):
or a salt thereof, wherein R
1
, G, L
1
, L
2
, L
3
, and Y are as described herein. Compounds of formula (I) and pharmaceutical compositions thereof are inhibitors of one, or both of, αvβ
1
integrin and αvβ
6
integrin that are useful for treating fibrosis such as in nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
本发明涉及如下公式(I)的化合物:
或其盐,其中R1、G、L1、L2、L3和Y如本文所述。公式(I)的化合物及其药物组合物是αvβ1整合素和/或αvβ6整合素的一种或两种的抑制剂,用于治疗纤维化,如非酒精性脂肪肝炎(NASH)、特发性肺纤维化(IPF)和非特异性间质性肺炎(NSIP)。